Evidence map›Paper›PMID 40308629›Full record

ArticleJournal of analytical methods in chemistry2025

Development of RP-HPLC Method for Simultaneous Determination of Triclabendazole and Ivermectin in Pharmaceutical Suspension Dosage Form.

Taj Ur Rahman, Ajmal Zaman, Ali Bahadur, Muhammad Aurang Zeb, Wajiha Liaqat, Eman Y Santali, Sarah Alharthi, Ruwida M K Omar, Saif A Alharthy, Ashraf Ali

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of analytical methods in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Taj Ur RahmanDepartment of Chemistry, Mohi-Ud-Din Islamic University, Nerian Sharif, Azad Jammu and Kashmir, Pakistan.
Ajmal ZamanDepartment of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.
Ali BahadurDepartment of Chemistry, School of Natural Sciences (SNS), National University of Science and Technology (NUST), H-12, Islamabad 46000, Pakistan.
Muhammad Aurang ZebDepartment of Chemistry, Mohi-Ud-Din Islamic University, Nerian Sharif, Azad Jammu and Kashmir, Pakistan.
Wajiha LiaqatDepartment of Chemistry, Mohi-Ud-Din Islamic University, Nerian Sharif, Azad Jammu and Kashmir, Pakistan.
Eman Y SantaliDepartment of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.
Sarah AlharthiDepartment of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Ruwida M K OmarPharmaceutical Chemistry Department, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya.
Saif A AlharthyDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.
Ashraf AliDepartment of Chemistry, Faculty of Physical and Applied Sciences, The University of Haripur, Haripur 22620, Pakistan.ORCID https://orcid.org/0000-0003-2472-0195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed for simultaneous determination of triclabendazole (TCB) and ivermectin (IVM) in pharmaceutical dosage form. A mobile phase consisting of acetonitrile/water (50:50 v/v) with a flow rate of 1.5 mL/min was used for chromatographic separation of the mixture of TCB and IVM. The developed method was found to be linear with the correlation coefficient (

Indexed as

liquid chromatographymethod developmentmethod validationpharmaceutical analysis

Identifiers

PMID40308629
PMCPMC12041623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.